Pfizer Ltd. - Research Center
500680 PFIZER Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sales | 2,610.99 | 2,238.55 | 2,151.65 | 2,081.50 | 1,968.51 |
| Operating profit | 835.73 | 712.12 | 572.56 | 565.20 | 500.29 |
| Interest | 10.49 | 15.11 | 10.85 | 1.29 | 0.42 |
| Gross profit | 887.89 | 778.13 | 745.73 | 731.30 | 614.16 |
| EPS (Rs) | 133.89 | 108.77 | 111.29 | 93.78 | 78.70 |
Annual
results in details
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Other income | 62.65 | 81.12 | 184.02 | 167.39 | 114.29 |
| Stock adjustment | -72.90 | 14.35 | -36.62 | -90.88 | 27.51 |
| Raw material | 354.29 | 334.74 | 345.21 | 343.65 | 302.52 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 403.67 | 361.06 | 364.51 | 323.84 | 314.29 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,090.20 | 816.28 | 905.99 | 939.69 | 823.90 |
| Provisions made | - | - | - | - | - |
| Depreciation | 115.00 | 109.41 | 103.24 | 71.39 | 66.25 |
| Taxation | 160.33 | 171.11 | 133.36 | 230.86 | 187.84 |
| Net profit / loss | 612.56 | 497.61 | 509.13 | 429.05 | 360.07 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 32.01 | 31.81 | 26.61 | 27.15 | 25.41 |
| GPM (%) | 33.21 | 33.54 | 31.93 | 32.52 | 29.49 |
| NPM (%) | 22.91 | 21.45 | 21.80 | 19.08 | 17.29 |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis